Pro 2014-027 (Jianfeng Group Accounting Policy Change Announcement)
Release time:
2020-08-05
Securities Code: 600668 Securities Short Name: Jianfeng Group Announcement No.: 2014-027
Bond Short Name: 13 Jianfeng 01 Bond Code: 122227
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Changes in the Company's Accounting Policy
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important Note:
l This change in accounting policy is a reasonable adjustment in accordance with the requirements of the Ministry of Finance of the People's Republic of China and will not have a significant impact on the Company's assets, liabilities, profit and loss, cash flow, etc.
1. Overview
The Ministry of Finance has successively revised and issued "Accounting Standards for Enterprises No. 9 - Employee Compensation" and "Accounting Standards for Enterprises No. 30 - Financial Statements Presentation" since 2014 "," Accounting Standards for Business Enterprises No. 33 - Consolidated Financial Statements "," Accounting Standards for Business Enterprises No. 39 - Fair Value Measurement "," Accounting Standards for Business Enterprises No. 40 - Joint Venture Arrangement "," Accounting Standards for Business Enterprises No. 2 - long-Term Equity Investments, Corporate Accounting Standards 41 - Disclosure of Interests in Other Entities, and Corporate Accounting Standards 37 - Presentation of Financial Instruments , and other eight specific standards, and requires that from 2014 7 1 to be implemented within the scope of all enterprises that implement the accounting standards for enterprises. 2014 7 February 23 , the Ministry of Finance issued the "Decision of the Ministry of Finance on Amending < Accounting Standards for Enterprises - Basic Standards > ", which will come into force on the date of promulgation. The China Securities Regulatory Commission issued the "Notice on Doing a Good Job in the Disclosure of Financial Information Related to Newly Promulgated or Revised Accounting Standards in the Quarterly Report of the Third Quarter of 2014". The Shanghai Stock Exchange also used the "Important Reminder" to remind listed companies to do a good job in implementing the new standards when preparing and reviewing the third quarter report. As a A- share listed company,
Company implemented the above revised accounting standards in the quarterly report of the third quarter of 2014 and made corresponding changes to the company's accounting policies. The remaining unchanged parts still adopt the relevant standards and relevant regulations promulgated by the Ministry of Finance on 2006
15 . The 19th meeting of the eighth board of directors of the company reviewed and approved the "Proposal on Changes in the Company's Accounting Policy" and agreed to the company's implementation of the above changes in accounting policies.
Details of 2. Accounting Policy Changes and Their Impact on the Company
1, Impact of Implementing Accounting Standards for Business Enterprises 2
- Long-Term Equity Investment on the Company's Financial Statements According to the Standards, for , "
equity investmentthat does not have control, joint control or significant influence on the invested unit and has no quotation in the active market and whose fair value cannot be reliably measured" shall be treated according to "Accounting Standards for Business Enterprises No. 22 No. -# Recognition and Measurement of 126 Financial Assets. From "Long-term equity investment " to "Available-for-sale financial assets. Impact of Changes in Long-term Equity Investment Standards on Consolidated Financial Reporting
Unit: Yuan Currency: RMBLong Term Equity Investment |
Available-for-Sale Financial Assets |
|
-105,000,000.00 |
105,000,000.00 |
|
-36,363,832.51 |
36,363,832.51 |
|
-66,362,988.10 |
66,362,988.10 |
|
-20,000,000.00 |
241 ,000,000 |
|
| # | Zhejiang Jiaxing Santa Building Materials Co., Ltd.
||
-924,803.00 |
924,803.00 |
|
-330,000.00 |
330,000.00 |
|
-1,200,000.00 |
1,200,000.00 |
|
-230,181,623.61 |
230,181,623.61 |
2
-Long-Term Equity Investments" on the Company's financial statements, the implementation of the remaining standards will not have a material impact on the Company's financial statements. This adjustment will not have a significant impact on the total assets, total liabilities, net assets, and net profit of the company 2013 and the interim report of this year.
Independent Opinions of 3. Independent Directors
The independent directors of the company expressed their independent opinions on this. They believed that: in accordance with the relevant regulations and requirements of the Ministry of Finance and the China Securities Regulatory Commission,has made changes to the company's accounting policies and made retrospective adjustments to the business accounting involved to make the company's accounting policies comply with the relevant regulations of the Ministry of Finance, the China Securities Regulatory Commission and the Shanghai Stock Exchange, it is in the interests of the Company and all shareholders to be able to objectively and fairly reflect the Company's financial position and results of operations. The decision-making process for this change in accounting policy is in compliance with relevant laws, regulations and the Company's Articles of Association, and does not harm the rights and interests of the Company and its small and medium shareholders.
Opinions of the 4. Board of Supervisors
The Board of Supervisors believes that this adjustment is a reasonable change and adjustment in accordance with the relevant accounting standards newly promulgated or revised by the Ministry of Finance in 2014. The implementation of the relevant accounting standards newly promulgated or revised by the Ministry of Finance in 2014 can more objectively and fairly reflect the company's financial situation and operating results; the relevant decision-making procedures are in compliance with relevant laws and regulations and the Company's Articles of Association, and there is no harm to the interests of the Company and its shareholders. The Supervisory Board agreed to change the Company's accounting policies in accordance with the relevant accounting standards newly issued or revised by the Ministry of Finance in 2014.5. Online Announcement Annex
(I) Independent Director's Opinions on Changes in Company Accounting Policies
(II) Company's 7th 13th Board of Supervisors Resolution Announcement
(III) Company's 8th 19th Board of Directors Resolution Announcement
This is hereby announced.
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
October 27, 2014
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11